Literature DB >> 10320373

Requirement for type 2 NO synthase for IL-12 signaling in innate immunity.

A Diefenbach1, H Schindler, M Röllinghoff, W M Yokoyama, C Bogdan.   

Abstract

Interleukin-12 (IL-12) and type 2 NO synthase (NOS2) are crucial for defense against bacterial and parasitic pathogens, but their relationship in innate immunity is unknown. In the absence of NOS2 activity, IL-12 was unable to prevent spreading of Leishmania parasites, did not stimulate natural killer (NK) cells for cytotoxicity or interferon-gamma (IFN-gamma) release, and failed to activate Tyk2 kinase and to tyrosine phosphorylate Stat4 (the central signal transducer of IL-12) in NK cells. Activation of Tyk2 in NK cells by IFN-alpha/beta also required NOS2. Thus, NOS2-derived NO is a prerequisite for cytokine signaling and function in innate immunity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10320373     DOI: 10.1126/science.284.5416.951

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  49 in total

Review 1.  Role of cytokines in the innate immune response to intracellular pathogens.

Authors:  S Stenger; M Röllinghoff
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

2.  Leishmania-infected macrophages are targets of NK cell-derived cytokines but not of NK cell cytotoxicity.

Authors:  Chittappen K Prajeeth; Simone Haeberlein; Heidi Sebald; Ulrike Schleicher; Christian Bogdan
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

Review 3.  Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling.

Authors:  Carl Nathan
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 4.  S-nitrosylation: physiological regulation of NF-kappaB.

Authors:  Harvey E Marshall; Douglas T Hess; Jonathan S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-08       Impact factor: 11.205

5.  Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection.

Authors:  G M Anstead; B Chandrasekar; W Zhao; J Yang; L E Perez; P C Melby
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

6.  All-trans-retinoic acid suppresses interferon-gamma and tumor necrosis factor-alpha; a possible therapeutic agent for rheumatoid arthritis.

Authors:  Yuji Nozaki; Chise Tamaki; Toshiaki Yamagata; Masafumi Sugiyama; Shinya Ikoma; Koji Kinoshita; Masanori Funauchi
Journal:  Rheumatol Int       Date:  2005-11-15       Impact factor: 2.631

7.  The quantity of nitric oxide released by macrophages regulates Chlamydia-induced disease.

Authors:  Jin Huang; Fred J DeGraves; Stephen D Lenz; Dongya Gao; Pu Feng; Dan Li; Tobias Schlapp; Bernhard Kaltenboeck
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

8.  A controlled, randomized-blinded clinical trial to assess the efficacy of a nitric oxide releasing patch in the treatment of cutaneous leishmaniasis by Leishmania (V.) panamensis.

Authors:  Patricio López-Jaramillo; Melvin Y Rincón; Ronald G García; Sandra Y Silva; Erin Smith; Piyaporn Kampeerapappun; Carlos García; Daniel J Smith; Marcos López; Iván D Vélez
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

9.  Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disordered macrophage inflammatory responses and reduced clearance of the pathogen, Staphylococcus aureus.

Authors:  A J Bune; A R Hayman; M J Evans; T M Cox
Journal:  Immunology       Date:  2001-01       Impact factor: 7.397

Review 10.  The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases.

Authors:  Christoph Hölscher
Journal:  Med Microbiol Immunol       Date:  2003-06-27       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.